OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML
Product details
Registration number: SIN16871P
Classification: Prescription Only
Active ingredients: Ocrelizumab
Strength: 300 mg/10 ml
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L04AG08
HSA approval date: 28 September 2023
Manufacturer(s):
- Roche Diagnostics GmbH
- F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND; GERMANY
What are the HSA registration number and classification for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16871P
Classification: Prescription Only
What active ingredients and strength are recorded for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ocrelizumab
Strength: 300 mg/10 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Roche Diagnostics GmbH
- F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND; GERMANY
Where can I look up OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16871P or the exact product name OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML. The general register link does not preselect this product.
What are the source dates for this OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16871P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)